Table of Contents

Section 1 Biosimilars/follow-on-biologics Market Overview

• 1.1 Biosimilars/follow-on-biologics Market Scope
• 1.2 COVID-19 Impact on Biosimilars/follow-on-biologics Market
• 1.3 Global Biosimilars/follow-on-biologics Market Status and Forecast Overview
  • 1.3.1 Global Biosimilars/follow-on-biologics Market Status 2016-2021
  • 1.3.2 Global Biosimilars/follow-on-biologics Market Forecast 2022-2027

Section 2 Global Biosimilars/follow-on-biologics Market Manufacturer Share

• 2.1 Global Manufacturer Biosimilars/follow-on-biologics Sales Volume
• 2.2 Global Manufacturer Biosimilars/follow-on-biologics Business Revenue

Section 3 Manufacturer Biosimilars/follow-on-biologics Business Introduction

• 3.1 Novartis (Sandoz) Biosimilars/follow-on-biologics Business Introduction
  • 3.1.1 Novartis (Sandoz) Biosimilars/follow-on-biologics Sales Volume, Price, Revenue and

Gross margin 2016-2021

• 3.1.2 Novartis (Sandoz) Biosimilars/follow-on-biologics Business Distribution by Region
• 3.1.3 Novartis (Sandoz) Interview Record
• 3.1.4 Novartis (Sandoz) Biosimilars/follow-on-biologics Business Profile
• 3.1.5 Novartis (Sandoz) Biosimilars/follow-on-biologics Product Specification

Revenue and Gross margin 2016-2021

• 3.2.2 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Business Distribution by

Region

• 3.2.3 Interview Record
• 3.2.4 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Business Overview
• 3.2.5 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Specification

Gross margin 2016-2021

• 3.3.2 Manufacturer three Biosimilars/follow-on-biologics Business Distribution by Region
• 3.3.3 Interview Record
• 3.3.4 Manufacturer three Biosimilars/follow-on-biologics Business Overview
• 3.3.5 Manufacturer three Biosimilars/follow-on-biologics Product Specification

…

Section 4 Global Biosimilars/follow-on-biologics Market Segmentation (By Region)

• 4.1 North America Country
  • 4.1.1 United States Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-

2021

• 4.1.2 Canada Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
• 4.1.3 Mexico Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021

2021

• 4.4 Europe Country
  • 4.4.1 Germany Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
  • 4.4.2 UK Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
  • 4.4.3 France Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
  • 4.4.4 Spain Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
  • 4.4.5 Italy Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
• 4.5 Middle East and Africa
  • 4.5.1 Africa Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
  • 4.5.2 Middle East Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-

2021

• 4.6 Global Biosimilars/follow-on-biologics Market Segmentation (By Region) Analysis

2016-2021

• 4.7 Global Biosimilars/follow-on-biologics Market Segmentation (By Region) Analysis

Section 5 Global Biosimilars/follow-on-biologics Market Segmentation (by Product Type)

• 5.1 Product Introduction by Type
  • 5.1.1 Human growth hormone Product Introduction
  • 5.1.2 Erythropoietin Product Introduction
  • 5.1.3 Monoclonal antibodies Product Introduction
  • 5.1.4 Insulin Product Introduction
  • 5.1.5 Interferon/Granulocyte-Colony Stimulating Factor Product Introduction
• 5.2 Global Biosimilars/follow-on-biologics Sales Volume by Erythropoietin016-2021
• 5.3 Global Biosimilars/follow-on-biologics Market Size by Erythropoietin016-2021
• 5.4 Different Biosimilars/follow-on-biologics Product Type Price 2016-2021
• 5.5 Global Biosimilars/follow-on-biologics Market Segmentation (By Type) Analysis

Section 6 Global Biosimilars/follow-on-biologics Market Segmentation (by Application)

• 6.1 Global Biosimilars/follow-on-biologics Sales Volume by Application 2016-2021
• 6.2 Global Biosimilars/follow-on-biologics Market Size by Application 2016-2021
• 6.2 Biosimilars/follow-on-biologics Price in Different Application Field 2016-2021
• 6.3 Global Biosimilars/follow-on-biologics Market Segmentation (By Application) Analysis

Section 7 Global Biosimilars/follow-on-biologics Market Segmentation (by Channel)

• 7.1 Global Biosimilars/follow-on-biologics Market Segmentation (By Channel) Sales Volume

and Share 2016-2021

• 7.2 Global Biosimilars/follow-on-biologics Market Segmentation (By Channel) Analysis

Section 8 Biosimilars/follow-on-biologics Market Forecast 2022-2027

• 8.1 Biosimilars/follow-on-biologics Segmentation Market Forecast 2022-2027 (By Region)
• 8.2 Biosimilars/follow-on-biologics Segmentation Market Forecast 2022-2027 (By Type)
• 8.3 Biosimilars/follow-on-biologics Segmentation Market Forecast 2022-2027 (By

Application)

• 8.4 Biosimilars/follow-on-biologics Segmentation Market Forecast 2022-2027 (By Channel)
• 8.5 Global Biosimilars/follow-on-biologics Price Forecast

Section 9 Biosimilars/follow-on-biologics Application and Client Analysis

• 9.1 Blood disorders Customers
• 9.2 Oncology diseases Customers
• 9.3 Chronic and autoimmune diseases Customers
• 9.4 Growth hormone deficiencies Customers

Section 10 Biosimilars/follow-on-biologics Manufacturing Cost of Analysis

11.0 Raw Material Cost Analysis

11.0 Labor Cost Analysis

11.0 Cost Overview

Section 11 Conclusion

Section 12 Methodology and Data Source

Chart and Figure

Figure Biosimilars/follow-on-biologics Product Picture

Chart Global Biosimilars/follow-on-biologics Market Size (with or without the impact of

COVID-19)

Chart Global Biosimilars/follow-on-biologics Sales Volume (Units) and Growth Rate 2016-

2021

Chart Global Biosimilars/follow-on-biologics Market Size (Million $) and Growth Rate 2016-

2021

Global Biosimilars/follow-on-biologics Market Status, Trends and COVID-19 Impact Report
2022
Single User License Report: 2350 USD
Corporate User License Report: 4700 USD
Section Price: As below
Page: 115
Chart and Figure: 142
Publisher: BisReport
Delivery Time: 48 hour



In the past few years, the Biosimilars/follow-on-biologics market experienced a huge
change under the influence of COVID-19, the global market size of Biosimilars/follow-on-
biologics reached xx million $ in 2021 from xx in 2016 with a CAGR of xx from 2016-2021 is.
As of now, the global COVID-19 Coronavirus Cases have exceeded 500 million, and the
global epidemic has been basically under control, therefore, the World Bank has estimated
the global economic growth in 2021 and 2022. The World Bank predicts that the global
economic output is expected to expand 4 percent in 2021 while 3.8 percent in 2022.
According to our research on Biosimilars/follow-on-biologics market and global economic
environment, we forecast that the global market size of Biosimilars/follow-on-biologics will
reach xx million $ in 2027 with a CAGR of % from 2022-2027.

Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.

The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Biosimilars/follow-on-biologics Market Status,
Trends and COVID-19 Impact Report 2022, which provides a comprehensive analysis of the
global Biosimilars/follow-on-biologics market , This Report covers the manufacturer data,
including: sales volume, price, revenue, gross margin, business distribution etc., these data
help the consumer know about the competitors better. This report also covers all the
regions and countries of the world, which shows the regional development status, including
market size, volume and value, as well as price data. Besides, the report also covers segment
data, including: type wise, industry wise, channel wise etc. all the data period is from 2016-
2021, this report also provide forecast data from 2022-2027.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)

Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)

Section (5 6 7): 700 USD——
Product Type Segmentation
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon/Granulocyte-Colony Stimulating Factor

Application Segmentation
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies

Channel (Direct Sales, Distribution Channel) Segmentation

Section 8: 500 USD——Market Forecast (2022-2027)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source